R&D Pipeline

Inventage Lab Pipeline Overview, Value Created Through Our DDS Platform

Our R&D pipeline comprises diverse development programs spanning from early to late stages, aimed at addressing unmet medical needs in intractable and chronic diseases. All candidates are based on our proprietary platforms — IVL-DrugFluidic®, IVL-BioFluidic™, and IVL-GeneFluidic® — and are designed to significantly enhance drug delivery efficiency and dosing persistence. We are also accelerating innovative therapeutic development through collaborations with domestic and international pharmaceutical companies.